Ovarian Cancer Screeings Not Worth Risk, Panel Says
Does not reduce deaths
Healthy women shouldn't take screening tests to spot ovarian cancer, a U.S. panel said, updating and reaffirming its 2004 recommendation against the procedure.
The U.S. Preventive Services Task Force reviewed studies that have been conducted since its earlier recommendation and found that ovarian cancer screening using transvaginal ultrasound and a blood test called CA-125 doesn't reduce the number of deaths from the disease, according to the recommendation published yesterday in the Annals of Internal Medicine. In particular, a U.S. study last year of 78,216 women found that those who were screened didn't have a lower death rate from the cancer than women who weren't tested.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?